Vergleich

GenCrispr NLS-Cas9-EGFP Nuclease Europäischer Partner

Hersteller GenScript
Kategorie
Typ Proteins
Specific against other
Menge 100 ug (3mg/ml)
ArtNr Z03393-100
eClass 6.1 34160400
eClass 9.0 42020190
Lieferbar
Description
GenCrispr NLS-Cas9-EGFP is a fusion protein developed by GenScript. It contains a nuclear localization sequence (NLS) on its N terminal and EGFP on the C terminal. Cas9 nuclease is an RNA-guided endonuclease that can catalyze cleavage of double stranded DNA. This kind of targeted nuclease is a powerful tool for genome editing with high precision. Cas9 protein forms a very stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR/Cas9 system. The Cas9 RNP complex can localize to the nucleus immediately upon entering the cell with the addition of a nuclear localization signal (NLS). There is no requirement for transcription or translation compared with mRNA or plasmid systems. Additionally, the Cas9 RNP complex is rapidly cleared from the cells minimizing the chance of off-target cleavage when compared to other systems (Kim, et al. 2014). The EGFP can be taken as a reporter for tracking or sorting transfected cells, which creates the possibility of enriching cell populations for desired genome edits via fluorescence activated cell sorting (FACS). It significantly reduces the labor and cost associated with single cell cloning and genotyping in genome editing applications. Product Source: GenCrispr NLS-Cas9-EGFP is produced by expression from an E. coli strain.KEY FEATURES . DNA-free: no external DNA added to system. High cleavage efficiency: NLS ensures the efficient entry of Cas9 protein into nuclei. Low off target: transient expression of Cas9 nuclease. Time-saving: no need for transcription and translation. Reduced-labor: enrich cell populations for desired genome edits via EGFP-based fluorescence activated cell sorting (FACS). . Utilities of Product . Screening for highly efficient and specific targeting gRNAs by in vitro DNA cleavage. In vivo gene editing when combined with a specific gRNA by electroporation or injection. Enrich cell populations for desired genome edits via EGFP-based fluorescence activated cell sorting (FACS). .
Shipping Temperature
4C
Storage Temperature
-20C
Manufacturers Category
Molecular Biology
Manufacturers Product Line
Genome Editing
Product Origin
USA

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 100 ug (3mg/ml)
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 09.05.2024 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen